Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis.
K
K
Winckers
A J
AJ
Ten Cate-Hoek
K C M M
KC
Beekers
P
P
Erkens
K
K
Hamulyák
H
H
Ten Cate
T M
TM
Hackeng
D000368:Aged; D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D017293:Protein S / Q000378:metabolism; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D013917:Thrombin / Q000378:metabolism; D013997:Time Factors; D014463:Ultrasonography; D054556:Venous Thromboembolism / Q000097:blood*; D020246:Venous Thrombosis / Q000097:blood* / Q000000981:diagnostic imaging
D008074:Lipoproteins; D017293:Protein S; C051928:lipoprotein-associated coagulation inhibitor; D013917:Thrombin